ConvaTec Group PLC (LON:CTEC – Get Free Report) has been assigned a consensus rating of “Buy” from the six brokerages that are covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is GBX 307.17 ($3.93).
Separately, Berenberg Bank restated a “buy” rating and issued a GBX 310 ($3.97) price target on shares of ConvaTec Group in a research report on Tuesday, June 11th.
Get Our Latest Stock Analysis on ConvaTec Group
ConvaTec Group Price Performance
About ConvaTec Group
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
See Also
- Five stocks we like better than ConvaTec Group
- ETF Screener: Uses and Step-by-Step Guide
- Top 3 Defense Stocks That Should Be on Your Radar
- Using the MarketBeat Dividend Yield Calculator
- Why This Banking Stock Might Be Nearing the Bottom of Its Cycle
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- MarketBeat Week in Review – 7/8 – 7/12
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.